PARIS (AP) – First, the French president suggested that the AstraZeneca vaccine was “ineffective” in protecting the elderly from COVID-19. Emmanuel Macron’s government is now asking people to take it.
Germany found itself in a similar situation.
Berlin changed its cautious policy this week after an independent vaccine committee said AstraZeneca shots should be used on people over 65, senior German officials argued on Friday against. “Buying the vaccine” and urging people to take precautions as possible.
Mixed messaging has confused or distrusted many in both countries with government recommendations about the AstraZeneca jab.Meanwhile, the infection in Europe is recovering and others across the continent and around the world are calling it. Demonstrates access to the COVID-19 vaccine they can receive.
The European government’s first hesitation about AstraZeneca’s vaccine is based on limited data on whether it can be used by people over 65, but new information on efficacy – and the pressure to accelerate the release of the vaccine at EU slowdown and use of unused AstraZeneca volumes – informed several European health officials. Countries this week to reverse the route and allow for use for all ages.
In France, everyone who works with sick or elderly people is eligible for the AstraZeneca vaccine for several weeks, but only 30% of them receive the vaccine. Some people argued that they needed the vaccine. Instead, Pfizer-BioNTech or Moderna, which is currently only available in France to seniors or people with pre-existing health conditions.
So, French Health Minister Olivier Veran sent a letter to all health officials on Friday urging them to get vaccinated. And if that doesn’t work, he says he can call a special ethics committee meeting to weigh the requirements for them to do so.
“Clearly (30%) was not enough,” Veran told a news conference on Thursday night. While showing respect to health workers, he said: “When you are a medical professional, you have a duty to protect … yourself and your patients.”
On his side, the family doctor echoed his plea, “I begging my colleague: Please come and get vaccinated,” said Dr. Marie-Laurel B, noting her patients are eager to get the vaccine. Any
The head of Germany’s disease control agency on Friday called on people to be vaccinated when the opportunity arises. Comments from Lothar Wieler, President of the Robert Koch Institute come amid reports that many in the country have denied that AstraZeneca fired, worried it might not work as well as others.
“If you are offered a vaccine, please get vaccinated yourself. They’re safe and effective, ”Wieler said, adding that vaccinating large numbers of people is the“ solution to the epidemic ”.
The vaccine, produced by British-Swedish company AstraZeneca, is one of three licensed for use in 27 EU countries, although it has not received the green light from U.S. regulators. EU countries are taking care of the vaccine. Pfizer-BioNTech and Moderna, too, said French nurse Michele Freret said she wanted one of them.
“If they vaccinated us with AstraZeneca and it was not as effective as Pfizer or any other drug, we would get COVID and no medical staff would take care of the people I look after,” she told The Associated Press.
She’s worried about the virus – “I’m constantly testing myself,” and the doctors and nurses lost their lives fighting it. But she said she and some of her colleagues felt the government was trying to get rid of the special AstraZeneca vaccine by inoculating medical staff.
France, with more than 87,000 deaths, is one of the highest coronavirus deaths in Europe, with as of Tuesday used just 25% of the 1.6 million AstraZeneca vaccines given the restrictive rules and rushed deliveries. Germany has sat on AstraZeneca volumes more than 2 million times this week.
France’s skepticism was repeatedly commented last month by Macron when he told reporters: “The real problem with AstraZeneca is that it doesn’t work as we expected … today everything points out. That it hardly works People over 65 ”hours after he spoke, the European Medicines Agency approved the use of the vaccine for all ages. But the damage to its image has already occurred.
Some also cited some confusing preliminary information about AstraZeneca’s effectiveness, or questioned whether it could work with the new virus strains.The company is developing new versions in response to the variation.
Europe’s efforts to restore the vaccine’s reputation came as new infections rose 9 percent across the continent in the past week, halting the six-week decline.
The rise of participation from Berlin.
Follow all AP outbreaks at: